TheBN13monoclonalantibodyreactswithhumanCTLA-4(cytotoxicTlymphocyteantigen-4)alsoknownasCD152.CTLA-4isa33kDacellsurfacereceptorencodedbytheCtla4genethatbelongstotheCD28familyoftheIgsuperfamily.CTLA-4isexpressedonactivatedTandBlymphocytes.CTLA-4isstructurallysimilartotheT-cellco-stimulatoryprotein,CD28,andbothmoleculesbindtotheB7familymembersB7-1(CD80)andB7-2(CD86).Uponligandbinding,CTLA-4negativelyregulatescell-mediatedimmuneresponses.CTLA-4playsrolesininductionand/ormaintenanceofimmunologicaltolerance,thymocytedevelopment,andregulationofprotectiveimmunity.ThecriticalroleofCTLA-4inimmunedown-regulationhasbeendemonstratedinCTLA-4deficientmice,whichsuccumbat3-5weeksofageduetothedevelopmentofalymphoproliferativedisease.CTLA-4isamongagroupofinhibitoryreceptorsbeingexploredascancertreatmenttargetsthroughimmunecheckpointblockade.TheBN13antibodyhasbeenshowntoneutralizeCTLA-4invitro.
| Isotype | MouseIgG2a, κ |
| RecomendedIsotypeControl(s) | InVivoMAbmouseIgG2aisotypecontrol,unknownspecificity |
| RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer |
| Immunogen | HumanCTLA-4recombinantprotein |
| ReportedApplications |
|
| Endotoxin |
|
| Purity |
|
| Formulation |
|
| Sterility | 0.2μMfiltered |
| Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
| Purification | ProteinG |
| Storage | Undilutedat4°Cinthedark |
